UPDATE 2-US approves Acorda MS drug to help with walking | Reuters
Acorda Therapeutics Inc
(ACOR.O) won U.S. approval on Friday for the first drug to
improve walking ability in patients with multiple sclerosis.
MS patients in clinical trials who took the oral drug,
Ampyra, had faster walking speeds than others who got a
placebo, the Food and Drug Administration said in a statement.
Acorda Therapeutics Inc
(ACOR.O) won U.S. approval on Friday for the first drug to
improve walking ability in patients with multiple sclerosis.
MS patients in clinical trials who took the oral drug,
Ampyra, had faster walking speeds than others who got a
placebo, the Food and Drug Administration said in a statement.
No comments:
Post a Comment